Kenneth Krogulski - 18 Mar 2026 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Reporting relationship: Director
Issuer ticker: CPIX
Reported as of: 18 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 20 Mar 2026, 17:22:02 UTC
Prior SEC filing: 06 Jan 2026
Source filing: View source filing
Reporting owner signature: Kenneth J. Krogulski by /s/ John Hamm as attorney-in-fact

Key filing fact

Kenneth Krogulski filed Form 4 for CUMBERLAND PHARMACEUTICALS INC (CPIX) on 20 Mar 2026.

Key facts

This page summarizes Kenneth Krogulski's Form 4 filing for CUMBERLAND PHARMACEUTICALS INC (CPIX).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 20 Mar 2026, 17:22.

Change

Previous filing in this sequence was filed on 06 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001695580 Primary reporting owner

Krogulski Kenneth

Relationship: Director
Address: 1600 WEST END AVE., SUITE 1300, NASHVILLE
Signature: Kenneth J. Krogulski by /s/ John Hamm as attorney-in-fact
Signature date: 20 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CPIX transaction

Common Stock

Award

Transaction value
Shares: +1,800
Change %: +0.61%
Price: $2.80^*
Shares after: 298,338
Date: 18 Mar 2026
Ownership: Direct

CPIX transaction

Common Stock

Award

Transaction value
Shares: +4,000
Change %: +1.3%
Price: $2.80^*
Shares after: 302,338
Date: 18 Mar 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .